Lido Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,263
Closed -$427K 2266
2026
Q1
$427K Buy
+2,263
New +$477K ﹤0.01% 1387
2024
Q4
Sell
-1,837
Closed -$305K 1601
2024
Q3
$305K Buy
1,837
+218
+13% +$33K ﹤0.01% 1155
2024
Q2
$215K Buy
+1,619
New +$195K ﹤0.01% 1262
2024
Q1
Sell
-2,936
Closed -$222K 1465
2023
Q4
$222K Buy
+2,936
New +$186K ﹤0.01% 1170
2023
Q3
Sell
-2,936
Closed -$239K 1309
2023
Q2
$239K Sell
2,936
-469
-14% -$33.4K ﹤0.01% 1038
2023
Q1
$202K Buy
3,405
+99
+3% +$5.5K ﹤0.01% 1007
2022
Q4
$161K Buy
+3,306
New +$153K ﹤0.01% 927

Other funds holding THC

Lido Advisors's THC Position: Q2 2026 in Review

Lido Advisors sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 2,263 shares — an estimated $427K sold.

Lido Advisors first reported a position in THC in Q4 2022 and held it in 7 quarters. The position peaked at $427K in Q1 2026. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Lido Advisors reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Lido Advisors sold 2,263 Tenet Healthcare shares in Q2 2026, an estimated $427K.
  • Lido Advisors first reported a position in Tenet Healthcare in Q4 2022 and held it in 7 quarters.
  • Lido Advisors's Tenet Healthcare position peaked at $427K in Q1 2026.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.